Kastalia Medrano

    Kastalia is Filter‘s deputy editor. She previously worked at a number of other media outlets and wouldn’t recommend the drug coverage at any of them. She also works with drug users in NYC and drug checkers in North Carolina to track hyperlocal supply changes, and cohosts a national stimulant users call with Isaac Jackson. She uses meth daily and other drugs sometimes.

    FDA Exempts Harm Reduction From Biggest Naloxone Access Restrictions

    On September 22, the Food and Drug Administration announced that harm reduction naloxone suppliers ...

    “Rainbow Fentanyl” Is Probably a Good Thing, at This Point

    When Toronto’s Moss Park Overdose Prevention Site opened as an unsanctioned service in August ...

    The Pfizer Naloxone Shortage Ends, Leaving Us With Just the Regular One

    [Read Filter‘s August 1 story introducing Remedy Alliance’s naloxone distribution here.]   In the ...

    Exclusive: For the First Time, Harm Reduction Gets a Naloxone of Its Own

    In late April 2021, a manufacturing disruption brought Pfizer’s naloxone production to a standstill, ...

    DULF Keeps Distributing Checked Drugs as Health Canada Flags Denial

    On May 4 in Vancouver’s Downtown Eastside, the Drug User Liberation Front (DULF) distributed ...

    DEA’s Rx Drug Take Back Day Branded Fun for All the Family

    The worst thing I’ve seen suggested at one of the Drug Enforcement Administration’s biannual ...

    The US Gets Its First Free, Rapid Drug-Checking Mail Program

    Traditionally, the conversation around US safe supply consists of saying that we don’t have ...

    Drug Euphoria Is a Good Thing, Actually

    Back before I’d ever heard of harm reduction, I spent a lot of time ...